Moderna
$185.98Change from previous close: −1.57%Absolute change: −$2.96
At a glance
- Revenue growth
- −39.93%
- 2025 vs 2024
- Net margin
- -145.2%
- 2024: -110.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 12,338 | 14,142 | 18,426 | 25,858 | 24,669 |
| Current assets | 6,544 | 8,099 | 10,325 | 13,431 | 16,071 |
| Cash and equivalents | 2,595 | 1,927 | 2,907 | 3,205 | 6,848 |
| Short-term investments | 3,204 | 5,098 | 5,697 | 6,697 | 3,879 |
| Receivables | 284 | 592 | 1,081 | 1,685 | 3,323 |
| Inventory | 153 | 117 | 202 | 1,168 | 1,728 |
| Net property, plant and equipment | 2,853 | 2,955 | 2,658 | 2,139 | 1,383 |
| Goodwill | 52.0 | 52.0 | 52.0 | 0.0 | — |
| Other intangible assets | 45.0 | 40.0 | 44.0 | — | — |
| Long-term investments | 2,342 | 2,508 | 4,743 | 8,360 | 6,843 |
| Current liabilities | 1,987 | 2,206 | 3,015 | 4,923 | 9,128 |
| Accounts payable | 317 | 405 | 520 | 487 | 302 |
| Long-term debt | 590 | — | — | — | — |
| Total debt | 1,305 | 747 | 1,243 | 1,200 | — |
| Total liabilities | 3,688 | 3,241 | 4,572 | 6,735 | 10,524 |
| Total equity (incl. minority) | 8,650 | 10,901 | 13,854 | 19,123 | 14,145 |
| Retained earnings | 7,223 | 10,045 | 13,606 | 18,320 | 9,958 |